These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11749025)

  • 1. Primidone-induced hyperammonemic encephalopathy in a patient with cerebral astrocytoma.
    Katano H; Fukushima T; Karasawa K; Sugiyama N; Ohkura A; Kamiya K
    J Clin Neurosci; 2002 Jan; 9(1):79-81. PubMed ID: 11749025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy.
    Baumgartner J; Hoeflich A; Hinterbuchinger B; Fellinger M; Graf I; Friedrich F; Frey R; Mossaheb N
    Am J Psychiatry; 2019 Nov; 176(11):900-903. PubMed ID: 31672038
    [No Abstract]   [Full Text] [Related]  

  • 11. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
    Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous incidence of total corpus callosum absence, porencephalia and cerebral astrocytoma].
    Günzel H; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Sep; 68(17):909-14. PubMed ID: 4458276
    [No Abstract]   [Full Text] [Related]  

  • 15. A case with hyperammonemic encephalopathy triggered by single dose valproate.
    Ciftci S; Guler A; Deveci E; Celebisoy N; Yuceyar N
    Neurol Sci; 2016 Dec; 37(12):2017-2018. PubMed ID: 27436290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
    Cherian KA; Legatt AD
    Pediatr Neurol; 2017 Aug; 73():88-91. PubMed ID: 28545673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral basal-ganglia involvement likely due to valproate-induced hyperammonemic encephalopathy.
    Joardar S; Das S; Chatterjee R; Guha G; Hasmi MA
    Neurol Sci; 2012 Aug; 33(4):919-22. PubMed ID: 22086613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.